 | Cara Therapeutics, Inc. | |||
| NGM : CARA || Location: United States | ||||
$0.71-0.0 (-0.14%) |
0.6 M | 0.63 - 0.72 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 2.577 M |
| March 15, 2024 | 2.482 M |
| Feb. 29, 2024 | 2.386 M |
| Feb. 15, 2024 | 2.233 M |
| Jan. 31, 2024 | 2.515 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.42 | -0.59 | -40.41% |
| 09/30/2023 | -0.53 | -0.52 | 1.96% |
| 06/30/2023 | -0.55 | -0.58 | -5.63% |
| 03/31/2023 | -0.53 | -0.49 | 7.88% |
| 12/31/2022 | -0.33 | -0.56 | -71.57% |
CARA Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 54.656M | Shares Float | 39.348M |
| Short Float | 2.577M | Market Cap | 38.81M |
| Institution ownership | 45.49% | Insider ownership | 14.583% |
| Earnings Date | 05/06/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -2.19 | Forward EPS | -1.02 |